Publication

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Chun-Hyung Kim, Harvard Medical SchoolMaureen K. Hahn, Vanderbilt University Medical CenterYoosook Joung, Sungkyunkwan University School of MedicineSusan L. Anderson, Harvard Medical SchoolAngela H. Steele, Vanderbilt University Medical CenterMichelle S. Mazei-Robinson, Vanderbilt University Medical CenterIan Gizer, Emory UniversityMartin H. Teicher, Harvard Medical SchoolBruce M. Cohen, Harvard Medical SchoolDavid Robertson, Vanderbilt UniversityIrwin Waldman, Emory UniversityRandy D. Blakely, Vanderbilt University Medical CenterKwang-Soo Kim, Harvard Medical School
Language
  • English
Date
  • 2006-12-12
Publisher
  • National Academy of Sciences
Publication Version
Copyright Statement
  • © 2006 by The National Academy of Sciences of the USA.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0027-8424
Volume
  • 103
Issue
  • 50
Start Page
  • 19164
End Page
  • 19169
Grant/Funding Information
  • This work was supported by National Institutes of Health Grants MH48866 and DC006501; and a NARSAD Independent award (to K.-S.K.); by National Institutes of Health Grant HL56693 (to R.D.B.); and by National Institute of Mental Health Grants K01-MH01818 (to I.D.W.) and F31-MH072083 (to I.G.).
Supplemental Material (URL)
Abstract
  • The norepinephrine transporter critically regulates both neurotransmission and homeostasis of norepinephrine in the nervous system. In this study, we report a previously uncharacterized and common A/T polymorphism at -3081 upstream of the transcription initiation site of the human norepinephrine transporter gene [solute carrier family 6, member 2 (SLC6A2)]. Using both homologous and heterologous promoter-reporter constructs, we found that the -3081(T) allele significantly decreases promoter function compared with the A allele. Interestingly, this T allele creates a new palindromic E2-box motif that interacts with Slug and Scratch, neural-expressed transcriptional repressors binding to the E2-box motif. We also found that both Slug and Scratch repress the SLC6A2 promoter activity only when it contains the T allele. Finally, we observed a significant association between the -3081(A/T) polymorphism and attention-deficit hyperactivity disorder (ADHD), suggesting that anomalous transcription factor-based repression of SLC6A2 may increase risk for the development of attention-deficit hyperactivity disorder and other neuropsychiatric diseases.
Author Notes
Keywords
Research Categories
  • Health Sciences, Mental Health
  • Psychology, Clinical
  • Biology, Genetics

Tools

Relations

In Collection:

Items